News

Jul 19, 2018 Mitotech partners with Essex Bio-Technology for a late-stage clinical program in Dry Eye Disease
Oct 24, 2017 Mitotech announces new Dry Eye data set supporting SkQ1’s novel mechanism of action
Apr 26, 2017 Mitotech's SkQ1 improved visual acuity in Leber's Hereditary Optic Neuropathy (LHON) patients
Apr 20, 2017 Mitotech’s SkQ1 and its potential for treating age-related disorders discussed in Fierce Biotech publication
Mar 21, 2017 Mitotech's lead compound significantly increased lifespan of rapidly aging mice
Feb 10, 2017 Mitotech discusses SkQ1 and Dry Eye Disease in a recent Fierce Biotech article
Feb 07, 2017 Mitotech will attend the Biotech and Money conference in London, Feb 7-8, 2017
Jan 20, 2017 Mitotech S.A. Developing a Dry Eye Treatment has been Granted Two U.S. Patents for Pharmaceutical Formulations
Sep 09, 2016 Mitotech S.A. is granted a patent in anti-aging
Jul 27, 2016 Mitotech S.A. announces its Ophthalmic Scientific Advisory Board
Mar 20, 2016 Oxidative stress and dry eye in Review of Ophthalmology
Mar 01, 2016 Mitotech S.A. to present at ARVO 2016
Feb 05, 2016 Mitotech CEO to present at the annual BIO CEO and Investor Conference 2016
Jan 25, 2016 Mitotech S.A. to initiate its first clinical study of a systemic formulation of SkQ1
Jan 10, 2016 Results of SkQ1 U.S. Phase 2 Clinical Study in Patients with Dry Eye Syndrome published in Advances in Therapy journal
Dec 27, 2015 Results of Mitotech’s Multicenter Clinical Study in Patients with Dry Eye Syndrome published in Advances in Therapy journal
Oct 16, 2015 Mitotech S.A. to present at the 2015 Sofinnova Japan Biopharma Partnering Conference
May 03, 2015 Mitotech’s posters at ARVO 2015 in Denver, May 3-7
Apr 23, 2015 Mitotech Announces Phase 2 Data Showing Positive Effect of SkQ1 in Patients with Dry Eye Syndrome
Apr 21, 2014 Mitotech S.A. announces the initiation of Phase II clinical trial in Dry Eye Patients Utilizing the Controlled Adverse Environment
May 14, 2013 Mitotech completes series of uveitis studies
Dec 09, 2012 Mitotech’s posters at ARVO 2015 in Denver, May 3-7
Jan 17, 2012 Mitotech initiated pre-clinical program for SkQ1 compound in the U.S.